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Abstract
Motivation: Although principal component analysis (PCA) is widely used for the dimensional
reduction of biomedical data, interpretation of PCA results remains daunting. Most existing
methods for interpreting principal components (PCs) attempt to explain each PC in terms of a
small number of variables by generating approximate PCs with few non-zero loadings. Although
these methods are useful when just a few variables dominate the population PCs, they are often
inadequate for characterizing the biological signal represented by the PCs of high-dimensional
genomic data. For genomic data, reproducible and biologically meaningful PC interpretation
requires methods based on the combined signal of functionally related sets of genes. While gene
set testing methods have been widely used in supervised settings to quantify the association of
groups of genes with clinical outcomes, these methods have seen only limited application for
testing the enrichment of gene sets relative to sample PCs.
Results: We describe a novel approach, principal component gene set enrichment (PCGSE),
for computing the statistical enrichment or depletion of gene sets relative to PCs computed from
genomic data. The PCGSE method performs a two-stage competitive gene set test using the
correlation between each gene and each PC as the gene-level test statistic with flexible choice
of both the gene set test statistic and the method used to compute the null distribution of
the gene set statistic. Using simulated data with simulated gene sets and real gene expression
data with curated gene sets, we demonstrate that biologically meaningful and computationally
efficient results can be obtained from a simple parametric version of the PCGSE method that
performs a correlation-adjusted two-sample t-test between the gene-level test statistics for gene
set members and genes not in the set.
Availability: http://cran.r-project.org/web/packages/PCGSE/index.html
Contact: rob.frost@dartmouth.edu or jason.h.moore@dartmouth.edu
1 Introduction
Developed independently by Karl Pearson (Pearson, 1901) and Harold Hotelling (Hotelling, 1933),
PCA is a well established statistical technique that performs a linear transformation of multivariate
data into a new set of variables, the principal components (PCs), that are linear combinations of the
original variables, are uncorrelated and have sequentially maximum variance (Jolliffe, 2002). The
solution to PCA is given by the spectral decomposition of the covariance matrix with the variance of
the PCs specified by the eigenvalues, arranged in decreasing order, and the PC directions specified
by the associated eigenvectors.
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In the biomedical domain, PCA has been extensively employed for the analysis of genomic data
including measures of DNA variation, DNA methylation, RNA expression and protein abundance
(Ma and Dai, 2011). Common features of these datasets, and the motivation for spectral decompo-
sition methods, are the high dimensionality of the feature space (i.e., from thousands to over one mil-
lion), comparatively low sample size (i.e., p≫ n) and significant collinearity between the features.
The most common uses of PCA with genomic data involve dimensionality reduction for visualization
(Alter et al., 2000; Hibbs et al., 2005)) or clustering of the observations (Yeung and Ruzzo, 2001),
with population genetics an important use case (Patterson et al., 2006). PCA has also been used as
the basis for feature selection (Lu et al., 2011), gene clustering (Hastie et al., 2000) and bi-clustering
(Kluger et al., 2003). More recent applications include dimensionality reduction prior to gene set
testing (Tomfohr et al., 2005; Kong et al., 2006; Ma and Kosorok, 2009; Bruckskotten et al., 2010;
Chen, 2011) and high-dimensional regression (Hastie et al., 2009).
Although PCA is a popular and effective tool for reducing the dimensionality of genomic data,
application of the method remains limited by the challenge of biological interpretation (Zou et al.,
2006; Ma and Dai, 2011). Because PCs are linear combinations of all original variables, which can
number from the thousands to the millions for genomic data sets, they typically lack any clear
biological meaning. While PCA may improve the performance of many statistical methods, e.g.,
better predictive accuracy in a regression context, the underlying model is often a black box.
Approaches for generating more interpretable PCs have evolved from component thresholding
(Jolliffe, 2002), simple components (i.e., PC loading vectors constrained to values from {−1, 0, 1})
(Vines, 2000) and rotation techniques (e.g., varimax) (Jolliffe, 1995) to sparse PCA methods, which
compute approximate PCs using cardinality (Moghaddam et al., 2006; d’Aspremont et al., 2007;
Sriperumbudur et al., 2011) or LASSO-based (Jolliffe et al., 2003; Zou et al., 2006; Shen and Huang,
2008; Witten et al., 2009) constraints on the component loadings. By generating approximate PCs
with few non-zero loadings, all of these techniques improve interpretability by associating only a
small number of variables with each PC. While such sparse PCA methods can be very effective
when the true population PCs are associated with only a few variables, they will fail to accu-
rately estimate the spectral structure of the data when the population PCs are defined by the
coordinated action of large groups of variables with small marginal effects. For genomic data, the
pathway-based patterns that dominate the robust structure of genetic associations with clinical
phenotypes (Allison et al., 2006), and are the motivation for traditional gene set testing methods
(Huang et al., 2009; Khatri et al., 2012), can be expected to also characterize the PCs of those
data sets. The PCs of genomic data are therefore more likely to be quantitatively described, in
a repeatable fashion, by collections of functionally related genes, e.g., gene sets from the Gene
Ontology (GO) (Ashburner et al., 2000) or pathways from the Kyoto Encyclopedia of Genes and
Genomes (KEGG) (Kanehisa and Goto, 2000), than by individual genes.
To support interpretation of PCs in terms of a priori variable groups, rather than just in-
dividual variables, sparse PCA methods have recently been extended to include structured sparse
penalties (Jenatton et al., 2010; Grbovic et al., 2012), such as the group lasso (Yuan and Lin, 2006;
Friedman et al., 2010) and overlapping group lasso (Liu and Ye, 2010; Obozinski et al., 2011). Al-
though structured sparse PCA techniques generate sparse PC loading vectors that reflect group
structure, these methods cannot be easily used to compute the statistical association between
variable groups and each PC in such a way that the variable groups can be ranked according to
deviation from a specific null hypothesis, as is done in traditional gene set testing. Matrix corre-
lation methods, such as Yanai’s GCD (Yanai, 1980; Jolliffe, 2002; Ramsay et al., 1984), have also
been used to quantify the association between groups of variables and one or more PCs. However,
because such matrix correlation methods compute the association of each variable group indepen-
dent of the variables that do not belong to the group, they can only be used for self-contained
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gene set tests (Goeman and Buehlmann, 2007) (Q2 in the terminology of Tian et al. (Tian et al.,
2005)) in a manner similar to Goeman and Buhmann’s globaltest (Goeman et al., 2004) and not
for competitive gene set testing (Q1 in the terminology of Tian et al.).
To date, competitive gene set testing relative to PCs has been limited to methods, such as
Fisher’s Exact Test, that are based on a 2 × 2 contingency table representing the association be-
tween gene set membership and a discretization of the ranked list of PC loading values (Roden et al.,
2006). Such contingency table tests have two key flaws: they rely on an arbitrary threshold of the
gene-level test statistic, which reduces statistical power and, more importantly, they are based on
the incorrect assumption of independence among the gene-level test statistics, causing them to gen-
erate high type I error rates (Goeman and Buehlmann, 2007; Barry et al., 2008; Wu and Smyth,
2012). These same flaws apply equally in the context of gene set testing relative to PCs. Because
of the anti-conservative nature of contingency table-based tests, and other approaches that assume
independence among gene-level test statistics under the null, the use of these methods for standard
gene set testing has been strongly discouraged in favor of techniques that preserve inter-gene corre-
lation, usually via permutation of the sample labels (Goeman and Buehlmann, 2007). Competitive
gene set testing methods that correctly account for correlation among gene-level test statistics,
either through sample permutation, parametric approximation of the sample permutation distri-
bution or correlation adjustment of parametric test statistics, include SAFE (Barry et al., 2005,
2008; Zhou et al., 2013), GSEA (Subramanian et al., 2005), GSA (Efron and Tibshirani, 2007) and
CAMERA (Wu and Smyth, 2012).
Although biologically meaningful and repeatable interpretation of the PCs of genomic data
requires approaches based on functional gene sets, researchers do not currently have access to
methods that competitively test the association between gene sets and PCs with correct handling
of inter-gene correlation to control type I errors. To address this gap, we have developed principal
component gene set enrichment (PCGSE), an approach for interpreting the PCs of genomic data
via two-stage competitive gene set testing in which the correlation between each gene and each
PC is used as a gene-level statistic with flexible choice of both the gene set test statistic and the
method used to compute the null distribution of the gene set statistic. Although described in the
context of functional gene sets and genomic data, the PCGSE method can be used to compute the
statistical association between any collection of variable groups and the PCs of an empirical dataset.
To enable the easy application of the PCGSE method by other researchers, we implemented the
PCGSE R package, which can be downloaded from the CRAN repository. Using simulated data
with simulated gene sets and real gene expression data with curated gene sets, we demonstrate
that biologically meaningful and computationally efficient results can be obtained from a simple
parametric version of the PCGSE technique, based on the CAMERA method (Wu and Smyth,
2012), that performs a correlation-adjusted two-sample t-test between the gene-level test statistics
for gene set members and genes not in the set.
2 Methods
2.1 PCGSE inputs
The PCGSE method takes the following data structures as input:
1. Matrix of genomic data: n×pmatrix X quantifying p genomic variables under n experimental
conditions, e.g., mRNA expression levels measuring using microarray technology. This data
will be modeled as a sample of n independent observations from a p-dimensional random vector
x. Although PCGSE does not have specific distributional requirements, sources of genomic
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data, especially gene expression data, are typically well represented by a multivariate normal
distribution ∼ N (µp×1,Σp×p), especially after appropriate transformations. Often, p≫ n.
X =


x1,1 · · · x1,p
...
. . .
...
xn,1 · · · xn,p

 (1)
where xi,j represents the abundance of genomic variable j under condition i. It is assumed
that any desired data transformations (e.g., log transformation of mRNA expression ratios,
etc.) have been performed and that missing values have been imputed or removed for a
complete case analysis.
2. Matrix of functional annotations: f × p binary annotation matrix A whose rows represent f
different biological functions, e.g., GO terms or KEGG pathways, and whose cells ai,j hold
indicator variables whose value depends on whether an annotation exists between the function
i and genomic variable j.
A =


a1,1 · · · a1,p
...
. . .
...
af,1 · · · af,p

 , ai,j = 1 [variable j has function i] (2)
3. Algorithm parameters: The PCGSE method requires the specification of parameters that
determine the gene-level statistic used to quantify association between genomic variables and
PCs, whether transformations are applied to the gene-level statistics, the type of statistic
calculated for each gene set and the method used to assess the significance of the gene set
statistic given a competitive null hypothesis.
2.2 PCGSE algorithm
Enrichment of the gene sets defined by A relative to one of the PCs of X is performed using the
following sequence of steps:
1. Perform PCA on a standardized version of X.
2. Compute gene-level statistics, zj , j = 1, ..., p, for all p genomic variables that quantify the
association between the genomic variable and the PC.
3. (Optional) Transform the gene-level statistics.
4. Compute gene set statistics, Sk, k = 1, ..., f , for all f gene sets defined by A using the gene-
level statistics, zj .
5. Determine the statistical significance of the gene set statistics according to a competitive null
hypothesis.
Each of these steps is explained in more detail in the sections 2.3 thru 2.7 below. Note that steps
2 thru 5 have close parallels to modules in Ackermann and Strimmer’s general modular framework
for gene set enrichment analysis (Ackermann and Strimmer, 2009).
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2.3 PCA for PCGSE
Because PCs are not invariant under scaling of the data (Jolliffe, 2002), PCA is performed on a
mean centered and standardized version of X:
X˜ =


x˜1,1 · · · x˜1,p
...
. . .
...
x˜n,1 · · · x˜n,p

 , xˆi,j = xi,j − x¯j
sxj
(3)
where x¯j is the mean value of the jth genomic variable computed over the n samples and sxj is the
sample standard deviation of the jth genomic variable. The PC loading vectors and variances of
X˜ are thus the eigenvectors and eigenvalues of the sample correlation matrix, S = 1/(n− 1)X˜T X˜,
rather than the sample covariance matrix. For computational efficiency, the PCA solution is realized
via the singular value decomposition (SVD) of X˜:
X˜ = UΣVT (4)
where the columns of V represent the PC loading vectors, the entries in the diagonal matrix Σ are
proportional to the square roots of the PC variances and the columns of UΣ are the PCs.
2.4 Gene-level statistics
The PCGSE method supports the following gene-level statistics for quantifying the association
between genomic variable j and the target PC. These statistics are represented using the notation
zj , j = 1, ..., p.
• PC loading. For genomic variable j and target PC m, the gene-level statistic is element vj,m
of matrix V from the SVD of X˜ as defined in (4).
• Pearson correlation coefficient. Where the correlation is computed between each genomic
variable and the target PC.
• Fisher-transformed Pearson correlation coefficient. This creates a statistic whose distribution
is approximately N (0, 1).
Because the Pearson correlation coefficients between genomic variables and PCs of the sample
correlation matrix are proportional to the PC loadings (see (5) below), all of these gene-level
statistics provide a measure of the correlation between genomic variables and PCs.
cor(X˜,UΣ) = cov(X˜,UΣ
√
1− nΣ−1)
=
1
n− 1(UΣV
T )TU
√
1− n
=
√
n− 1
n− 1 VΣU
TU =
1√
n− 1VΣ
(5)
where U,Σ and V are from the SVD of X˜ as specified in (4).
The choice between the different gene-level statistics will be guided by the gene set statistic
and significance testing method employed for PCGSE as well as computational constraints. For
example, the added computational expense to generate z-statistics from correlation coefficients is
motivated by parametric tests of the mean difference statistic, whereas, for rank sum tests, the PC
loadings are sufficient.
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2.5 Transformation of gene-level statistics
An absolute value transformation can optionally be applied to the gene-level statistics, i.e., z˜j = |zj |.
Such a transformation gives the PCGSE method increased power to detect scale alternatives, i.e.
gene sets that contain both significantly enriched and significantly repressed genomic variables,
whereas the use of untransformed gene-level statistics provides better power against shift in location
alternatives, i.e., gene sets containing genomic variables with a common direction of association
(Efron and Tibshirani, 2007).
2.6 Gene set statistics
The PCGSE method supports two competitive gene set statistics for quantifying the association
between gene set k and a target PC. These statistics are represented using the notation Sk, k =
1, ..., f .
2.6.1 Mean difference statistic
This statistic is computed as the standardized difference between the mean of the zj for genomic
variables in the gene set and genomic variables not in the set and corresponds to UD in the notation
of Barry et al. (2008). Benefits of the mean difference statistic include its parametric null distribu-
tion and excellent power, relative to other gene set test statistics, for shift in location alternatives
when using untransformed zj (Efron and Tibshirani, 2007). For gene set k, this statistic is defined
as:
Sk =
z¯k − z¯kc
σp
√
1
mk
− 1
p−mk
(6)
mk =
p∑
j=1
ak,j, z¯k =
∑p
j=1 ak,jzj
mk
, z¯kc =
∑p
j=1!ak,jzj
p−mk
where mk is the number of genes in set k, z¯k is the mean of the zj for members of gene set k, z¯kc
is the mean of the zj for genes not in set k and σp is the pooled standard deviation of the zj .
2.6.2 Rank sum statistic
This statistic is computed as the standardized Wilcoxon rank sum statistic given the ranks of the
zj for genomic variables in the set and genomic variables not in the set and corresponds to UW in
the notation of Barry et al. (2008). Benefits of the rank sum statistic include lack of distributional
assumptions and robustness to outliers. For gene set k, the Wilcoxon rank sum statistic is defined
as the sum of the ranks of the gene-level statistic for all genomic variables belonging to gene set k
minus the minimum possible value for this sum of ranks:
Wk =
p∑
j=1
ak,jRank(zj)− mk(mk + 1)
2
(7)
where mk =
∑p
j=1 ak,j, the size of gene set k. A version of this statistic that has an asymptotic
N (0, 1) distribution under the null can be generated as:
Sk =
Wk − µWk
σ2Wk
(8)
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where µWk = (mk(p−mk))/2 and σ2Wk = (mk(p−mk)(mk + 1))/12.
Although it is possible to use any of the supported gene-level statistics with either of the gene set
statistics, as discussed above, the mean difference statistic should be used with Fisher-transformed
Pearson correlation coefficients and the rank sum statistic can be effectively used with just the PC
loading elements.
2.7 Gene set statistical significance
To compute the statistical significance of the association between gene set k and a target PC, the
distribution of the gene set statistic Sk must be calculated under the appropriate null hypothesis.
The PCGSE approach supports three different methods (parametric, correlation-adjusted paramet-
ric and permutation) for computing the competitive null distributions of the mean difference and
rank sum gene set statistics defined in (6) and (8).
2.7.1 Parametric tests
Under the competitive H0 that the zj are independent and identically distributed, it is possible
to determine the statistical significance of the association between each gene set and the target
PC using a two-sided t-test for the mean difference statistic or a two-sided z-test for the rank sum
statistic. Both of these parametric tests fall into the class 1 test category as outlined in Barry et al.
(2008) and are similar to the Q1 test defined by Tian et al. (2005).
Under this H0, the mean difference statistic defined in (6) has a t-distribution with p − 2 df
and a two-sided t-test can therefore be used to determine statistical significance. For the rank sum
statistic defined in (8), the asymptotic standard normal distribution under this H0 can be used as
the basis for a two-sided z-test.
While it is often safe to assume a normal distribution for the zj , especially after transformation,
the zj will not be independent. Indeed, because the zj used with PCGSE are proportional to the
PC loadings, they have an asymptotic multivariate normal distribution (Anderson, 1963), assuming
multivariate normality for the underlying genomic data, with significant correlation present between
the loadings associated with the genes that have high pair-wise correlations (Jolliffe, 2002). Because
both the t-test for the mean difference statistic and the z-test for the rank sum statistic ignore this
correlation between gene-level statistics, they will generate inflated type I error rates. These tests
are therefore only supported by the PCGSE method for the purpose of comparative evaluation.
2.7.2 Correlation-adjusted parametric tests
A computationally efficient approach for addressing correlation among the zj involves the use of
correlation-adjusted parametric tests. Correlation-adjusted versions of the t-statistic associated
with the mean difference statistic defined in (6) and of the z-statistic associated with the rank sum
statistic defined in (8) were first discussed in the context of gene set testing by Barry et al. (2008).
Simplified versions of these correlation-adjusted statistics were later developed into the CAMERA
method by Wu and Smyth (2012). Specifically, the approach taken by CAMERA assumes that
correlation among the zj can be approximated by the correlation among the genomic variables
(this is supported by results in Barry et al. (2008)), ignores all inter-gene correlation except the
correlation among the members of the tested gene set and estimates a single average pair-wise
correlation for gene set members using residuals from a linear regression.
The PCGSE method makes similar simplifying assumptions as those made by CAMERA ,
i.e., correlation between the zj can be approximated by correlation among the genomic variables,
only gene set members have non-zero inter-gene correlation and all pair-wise correlations between
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gene set members are the same. An important difference between PCGSE and CAMERA is that
PCGSE estimates the average inter-gene correlation directly from the sample correlation matrix.
The correlation-adjusted mean difference statistic used by PCGSE is:
Sadjk =
z¯k − z¯kc
σp
√
VIF
mk
− 1
p−mk
(9)
where VIF (variance inflation factor)= 1 + (mk − 1)ρ¯k and ρ¯k is the average unbiased sample
correlation between members of gene set k. Following Wu and Smyth (2012), this correlation-
adjusted statistic has a t-distribution with n − 2 df under H0. Likewise the correlation-adjusted
rank sum statistic is computed as:
Sadjk =
Wk − µWk
σ2
VIF,Wk
(10)
where σ2
VIF,Wk
= (mk(p − mk))/(2pi)(sin−1(1) + (p − mk − 1)sin−1(.5) + (mk − 1)(p − mk −
1)sin−1(ρ¯k/2) + (mk − 1)sin−1((ρ¯k + 1)/2)), as derived in Wu and Smyth (2012) based on the
formula in Barry et al. (2008).
2.7.3 Permutation test
The most common approach in the gene set testing literature for addressing correlation between
gene-level statistics has been sample permutation. This approach, which corresponds to the class 2
test in Barry et al. (2008), generates the null distribution of the gene set statistic via permutation
of the outcome variable. For each permutation of the outcome variable, all gene-level statistics are
recomputed to generate permutation statistics z∗j and then permutation gene set statistics S
∗
k are
calculated using the z∗j . The statistical significance for a given gene set k is based on the proportion
of all permutation S∗k more extreme than the observed Sk. In standard gene set testing, permutation
is applied to a clinical outcome variable, e.g., a case/control label. For PCGSE, permutation is
applied to the elements of the target PC, i.e., the elements of one of the columns of UΣ. Because
permutation is applied to the PC elements, this test can only be used with Pearson correlation
coefficients or Fisher-transformed Pearson correlation coefficients as gene-level statistics.
A key assumption of the permutation null distribution is that the permuted values are i.i.d.
Assuming the original n observations of the p-dimensional random vector x are i.i.d, the elements
of each PC will also be i.i.d., since each PC is a linear function of the original x. Permutation of
the PC elements therefore generates a valid permutation distribution for the mean difference and
rank sum gene set statistics.
Because permutation tests handle correlation among the zj without attempting to estimate this
correlation or make simplifying assumptions about the correlation structure, they are likely the
most accurate of the statistical tests supported by PCGSE and are therefore used to evaluate the
performance of the parametric and correlation-adjusted parametric tests. The exact permutation
test was also used as a ”gold-standard” in Zhou et al. (2013). Although they provide superior
handling of inter-gene correlation, permutation tests do suffer from two important disadvantages
relative to parametric tests: computational complexity and lower power to detect gene sets whose
members all have a small common association with the outcome. Because of these disadvantages,
correlation-adjusted parametric tests are preferred for most PCGSE applications.
Another alternative to sample permutation testing that addresses the key challenge of com-
putational complexity is the parametric approximation of the sample permutation distribution
of gene-level score statistics developed by Zhou et al. (2013). Although the Zhou et al.’s beta
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distribution-based parametric approximations may be a useful option for the PCGSE method, it is
not currently supported due to the lack of a parametric approximation for a directional, competitive
gene set test statistic that is equivalent to the standardized mean difference statistic using untrans-
formed directional gene-level test statistics. In Zhou et al. (2013), parametric approximations are
only detailed for two self-contained gene set test statistics (sum of the score statistics and sum of
the squares of the score statistics) and one non-directional competitive test statistic (a weighted
sum of the squares of local score statistics).
2.8 PCGSE output
For each of the f gene sets defined in A and each tested PC of X˜, the PCGSE method outputs
the observed value of the gene set test statistic, Sk, and a p-value representing the probability
of encountering a gene set statistic as or more extreme than then the observed Sk under the
appropriate competitive null hypothesis.
2.9 PCGSE evaluation
2.9.1 Evaluation using simulated gene sets and simulated data.
As a simple example, the PCGSE method was used to compute the statistical association between
20 disjoint gene sets, each of size 10, against the PCs of 100 simulated gene expression datasets
each comprised by 50 independent observations of a 200-dimensional random vector simulated
according to a multivariate normal distribution ∼ MVN(µ,Σ). The population covariance matrix,
Σ, was generated as: Σ = λ1α1α
T
1
+ λ2α2α
T
2
+ λdI, where λ1 = 2, λ2 = 1,λd = 0.1, α1 is a
200-dimensional vector with all elements equal to 0 except for the first 10 which were set to
√
.1,
α2 is a 200-dimensional vector with all elements equal to 0 except for the second 10 which were set
to
√
.1. Figure 1 shows the variance and loadings for both population and sample PCs simulated
according to this model.
For this simulated example, the PCGSE method was executed using the Fisher-transformed
Pearson correlation coefficient between each variable and each PC as the gene-level test statistic
with the standardized mean difference, as defined in (6), as the gene set test statistic. The statistical
significance of the association between each of the 20 simulated gene sets and each PC was computed
using all supported tests described in Section 2.7: parametric, correlation-adjusted parametric and
permutation. For the standardized mean difference gene set statistic, these tests were realized by
a two-sided t-test, a correlation-adjusted two-sided t-test and a two-sided permutation test based
on permutation of the PC elements, respective.
Because the true association was known between simulated gene sets and the PCs of the sim-
ulated data, it was possible to compute contingency table statistics. In this case, the type I error
rates for the different statistical testing methods were computed for gene set 2 relative to PC 1 and
for gene set 1 relative to PC 2, both cases with no true association.
2.9.2 Evaluation using Spellman et al. α factor-synchronized yeast gene expression
data and yeast cell cycle gene sets.
The PCGSE method was used to compute the statistical association of the yeast cell cycle gene sets
defined by Spellman (Spellman et al., 1998) relative to the first three PCs of a specially processed
version of the α factor-synchronized yeast gene expression data collected by Spellman et al. (1998)
and re-examined by Alter et al. (2000).
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Both the α factor-synchronized data and yeast cell cycle gene sets were downloaded from the
supplementary material website for Alter et al. (2000). To support comparison against the results
reported in Alter et al. (2000), PCA was performed on a version of the gene expression data that
was specially processed according to the steps outlined in Alter et al. (2000) so that the first three
PCs were identical to the first three so-called eigengenes. Figure 3 is a reproduction of Figure 5 from
Alter et al. (2000) with the value of the first three PCs of the specially processed gene expression
data (i.e., the eigengenes) shown relative to the 22 α factor arrays.
The PCGSE method was executed on the Spellman et al. data and gene sets using the Fisher-
transformed Pearson correlation coefficient between each gene and each PC as the gene-level test
statistic and the standardized mean difference, as defined in (6), as the gene set statistic. Similar to
the simulation example outlined in Section 2.9.1, the statistical significance of the gene set statistic
was computed using all supported tests described in Section 2.7.
2.9.3 Evaluation using MSigDB C2 v4.0 gene sets and Armstrong et al. leukemia
gene expression data.
The PCGSE method was also used to compute the statistical association between the MSigDB C2
v4.0 gene sets and the first 3 PCs of the leukemia gene expression data (Armstrong et al., 2002)
used in the 2005 GSEA paper (Subramanian et al., 2005).
The MSigDB C2 v4.0 cancer modules and collapsed leukemia gene expression data were both
downloaded from the MSigDB repository. With a minimum gene set size of 15 and maximum gene
set size of 200, 3,076 gene sets out of the original 4,722 were used in the analysis. Similar to the
simulation example outlined in Section 2.9.1 and the yeast cell cycle example outlined in Section
2.9.2, the PCGSE method was executed using the Fisher-transformed Pearson correlation coefficient
between each genomic variable and each PC as the gene-level test statistic and the standardized
mean difference, as defined in (6), as the gene set test statistic. The statistical significance of the
association between each of the MSigDB C2 gene sets and each of the first 3 PCs of the standardized
leukemia gene expression data was computed using all supported tests described in Section 2.7.
The enrichment of the MSigDB C2 gene sets was also computed relative to the acute myeloid
leukemia (AML) versus acute lymphoblastic leukemia (ALL) phenotype using the GSA method
(Efron and Tibshirani, 2007) with the restandardized mean statistic and 10,000 permutations. For
each of the first three PCs and each of the PCGSE methods for computing statistical significance
of the standardized mean difference gene set statistic, the Spearman correlation coefficient was
computed between PC gene set enrichment p-values and phenotype enrichment p-values. For PC
2, for which the PC and phenotype gene set enrichment p-values were highly correlated, contingency
table statistics were computed measuring how well PCGSE was able to identify MSigDB C2 gene
sets significantly associated with the AML/ALL phenotype.
3 Results and Discussion
3.1 Enrichment of simulated gene sets relative to PCs of simulated data
According to the population covariance matrix, Σ, used to simulate the 100 datasets, only the first
gene set should be significantly enriched on the first PC and only the second gene set should be
significantly enriched on the second PC. This relationship can seen easily in the loading values for
population PCs 1 and 2 as shown in Figure 1 plots (c) and (e). The significant loading of gene set
2 on PC 2, however, will result in a high pair-wise correlation between the PC loadings for gene
set 2 members on PC 1. The fact that high loadings on one PC result in correlation among the PC
10
Figure 1: Simulation model. Variances and loadings for the principal components a 200-
dimensional population covariance matrix, Σ, and the sample covariance matrix estimated from
n=50 independent observations of the random vector x ∼ MVN(0,Σ) where Σ is generated ac-
cording to the model outlined in Section 2.9.1. Variances for the first ten population PCs are shown
in plot (a) and loadings for the first two population PCs are shown in plots (c) and (e). Plots
(b), (d) and (f) show the corresponding variances and loadings for the sample PCs of a single
simulated dataset.
loadings on other PCs follows from the formula for the asymptotic distribution of the PC loadings
for MVN data (Anderson, 1963):
vj ∼ N (αj,Tj), j = 1, ..., p (11)
Tj =
λj
n− 1
p∑
k=1,k 6=j
λkαkαk
T
(λk − λj) (12)
where
• p is fixed and n→∞.
• λj an eigenvalue of the population covariance matrix, λ1 > λ2 > ... > λp.
• αj is an eigenvector of the population covariance matrix.
The gene-level test statistics computed for gene set 2 on PC 1 and for gene set 1 on PC 2 will
therefore have a non-zero average pair-wise correlation. The impact of this correlation between
the gene-level test statistics can be seen in the PCGSE results shown in Figure 2. The unadjusted
t-test uses an incorrectly small variance for the mean difference statistic and, as expected, generates
the high type I error rate of 0.42 given a nominal α of 0.05 for gene set 2 relative to PC 1 and
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Figure 2: Simulation results. Distribution of PCGSE-computed enrichment p-values for the first
10 of 20 simulated gene sets relative to the first 2 PCs of 100 datasets simulated according to the
model described in Section 2.9.1 and illustrated in Figure 1. The PCGSE method was executed
using parameter settings outlined in Section 2.9.1. For all displayed results, PCGSE was executed
using the Fisher-transformed Pearson correlation coefficient between each genomic variable and
each PC as the gene-level test statistic and the standardized mean difference as the gene set test
statistic. Plots (a), (b) and (c) display the distribution of enrichment p-values for the first 10
gene sets relative to the first PC of all simulated data sets. In plots (d), (e) and (f), enrichment
p-values computed relative to the second PC are displayed. For plots (a) and (d), the p-values
were computed using a two-sided t-test on the standardized mean difference gene set test statistic,
for plots (b) and (e), the p-values were computed using a two-sided correlation-adjusted t-test
and, for plots (c) and (f), the p-values were computed using a two-sided permutation test.
0.3 for gene set 1 relative to PC 2. The correlation-adjusted two-sided t-test and the two-sided
permutation test are much more successful at controling the type I error rate. For PC 1 and gene
set 2, the type I error rate was 0.13 for both correlation-adjusted t-test and the permutation test.
For PC 2 and gene set 1, the type I error rate was 0.06 for both the correlation-adjusted t-test and
the permutation test. For this example, all gene set testing methods were able to correctly reject
the null hypothesis for almost all cases where the gene set had a true association with the PC, e.g.,
gene set 1 relative to PC 1 and gene set 2 relative to PC 2.
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Although based on a simple two-factor MVN model, this simulation example demonstrates the
importance of controlling for correlation between gene-level test statistics when computing PC
gene set enrichment. Tests which assume independence among the statistics that quantify the
association between genes and PCs, such as a two-sample t-test, Fisher’s exact test or a gene
permutation test, will underestimate the variance of the gene set test statistic and therefore reject
too many null hypotheses. This example also shows that the correlation-adjusted t-test can achieve
enrichment sensitivity and specificity comparable to a sample permutation test with a significantly
lower computational burden.
PCGSE was was computed for this simulation example using the standardized rank sum as
the gene set statistic. The results for the standardized rank sum statistic using parametric and
permutation tests are similar to those for the standardized mean difference statistic. Although the
correlation-adjusted z-test based on the standardized rank sum statistic has an improved type I
error rate, it has an inflated type II error rate, i.e., it rejects too few null hypotheses when the
association is true. The inflated type II error rate for the correlation-adjusted rank sum z-test is
likely due to an overestimated VIF under the alternative hypothesis, as computed by the equation
from Barry et al. (2008). Therefore, in cases where a rank sum gene set statistic is motivated,
PCGSE should be performed using a permutation test and not using the more efficient correlation-
adjusted z-test.
3.2 Enrichment of Spellman et al. yeast cell cycle gene sets relative to the PCs
of Spellman et al. α-synchronized yeast gene expression data
Figure 3: Reproduction of Figure 5 from Alter et al. (2000) that displays the value of first three
PCs of the specially processed gene expression matrix, i.e., the ”eigengenes”, over the 22 α factor-
synchronized arrays. According to Alter et al. (2000), the following approximate mapping held
between arrays and cell cycle phases: 1 (NA), 2 (M/G1), 3,4 (G1), 5,6 (S), 7,8 (S/G2), 9 (G2/M),
10,11 (M/G1), 12,13 (G1), 14,15 (S), 16 (S/G2), 17,18 (G2/M), 19,20 (S/G1), 21,22 (G1)
The Spellman et al. (1998) α factor-synchronized gene expression data was selected for PCGSE
analysis because it is well known, has been widely reanalyzed, is easily accessible and has a spectra
with a published biological interpretation. In particular, the reanalysis by Alter et al. (2000) was
one of the first to illustrate that the spectra of gene expression data can represent important
biological features, in this case phases of the yeast cell cycle. In Alter et al. (2000), the authors
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T-test Cor-adj t-test Perm
PC 1 PC 2 PC 1 PC 2 PC 1 PC 2
M/G1 0.68 1.2e-12 0.94 0.18 0.94 0.22
G1 3.5e-130 1e-35 0.023 0.23 0.024 0.35
S 1e-10 0.0074 0.2 0.59 0.2 0.62
S/G2 0.27 4.6e-06 0.86 0.45 0.87 0.47
G2/M 8.3e-38 0.068 0.07 0.79 0.048 0.81
Table 1: PCGSE computed enrichment p-values for the Spellman et al. (1998) yeast cell cycle
gene sets relative to the first two PCs of the Spellman et al. (1998) α factor-synchronized gene
expression data processed using the steps outlined in Alter et al. (2000). PCGSE was executed
using Fisher transformed Pearson correlation coefficients between genes and PCs as gene-level test
statistics. Significance of the standardized mean difference gene set statistic was computed using
either a two-sided t-test, a correlation-adjusted two-sided t-test or a two-sided permutation test.
Unadjusted p-values less than 0.05 are displayed in bold.
provided a qualitative interpretation of the first two eigengenes in terms of the yeast cell cycle by
examining the correlation between the eigengenes and genes known to be active during different
cell cycle phases, as defined by Spellman et al.’s yeast cell cycle gene sets. Alter et al. concluded
that the first eigengene was correlated with genes that peak late in cell cycle phase G1 and early
in phase S and was anticorrelated with genes that peak late in cell cycle phase G2/M and early in
phase M/G1. Alter et al. also concluded that the second eigengene was correlated with genes that
peak late in cell cycle phase M/G1 and early in phase G1 and was anticorrelated with genes that
peak late in phase S and early in phase S/G2.
Table 3.2 contains p-values representing the statistical significance of the association between
each of the Spellman et al. yeast cell cycle gene sets and the first two PCs of a specially processed
version of the Spellman et al. gene expression data. As described in Section 2.9.2, this special pro-
cessing ensured that the PCs were identical to the eigengenes analyzed in Alter et al. (2000). When
a unadjusted two-sided t-test was used to determine the statistical significance of the standardized
mean difference gene set statistic, the gene sets corresponding to cell cycles G1, S and G2/M were
all highly significantly associated with PC 1 and the gene sets corresponding to M/G1, G1, S and
S/G2 were all significantly associated with PC 2. However, when either a correlation-adjusted
two-sided t-test or two-sided permutation was used to determine the statistical significance of the
standardized mean difference set statistic, PC 1 only had a significant association with the gene set
corresponding to phase G1 (with a marginally significant association with phase G2/M) and none
of the cell cycle gene sets were significantly associated with PC 2.
Comparing the output from PCGSE with the analysis in Alter et al. (2000), the results from
the unadjusted two-sided t-test align closely with the qualitative conclusions of Alter et al. The
output from the correlation-adjusted t-test and permutation test, although generally in agreement
for PC 1, are in direct contract with Alter et al. regarding PC 2, finding no cell cycle association.
The agreement between Alter et al. and the unadjusted t-test results is expected since the authors
had based their analysis simply on a qualitative inspection of the gene-level correlations without
a more formal test of a gene set test statistic that took account of the correlation between the
gene-level test statistics associated with each cell cycle phase. The fact that the more accurate
PCGSE methods failed to find an association between PC 2 and the cell cycle gene sets indicates
that the originally published association in Alter et al. (2000) was a false positive due to either the
high inter-gene correlation present among the members of these sets or the selective examination
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by Alter et al. on a subset of the genes in each of the cell cycle gene set with a common direction
of association with the eigengene. In the later case, it is likely that a gene set statistic such as
the maxmean (Efron and Tibshirani, 2007) would identify significant cell cycle enrichment for the
second eigengene.
This example highlights the importance of using formal statistical methods for gene set testing
when attempting to interpret the PCs of genomic data in terms of gene sets. Such gene set testing
methods must specifically account for the correlation between gene-level test statistics.
3.3 Enrichment of MSigDB C2 v4.0 gene sets relative to PCs of Armstrong et
al. leukemia gene expression data
The classic Armstrong et al. (2002) leukemia gene expression dataset is another excellent example
of a case where the genomic patterns associated with an interesting phenotype have a clear repre-
sentation in the spectral structure of the data. For the Armstrong et al. data, the second PC of
the gene expression data is strongly associated with the AML versus ALL status of the subjects.
Use of the Armstrong et al. gene expression data and MSigDB C2 v4.0 gene sets for evaluation of
PCGSE was also motivated by the extensive use of this dataset and gene set collection in the gene
set enrichment literature (e.g., Subramanian et al. (2005)) and easy accessibility from the MSigDB
repository, factors that will facilitate interpretation and replication of the reported PCGSE results
by other researchers.
Figure 4 shows the association between phenotype and PC gene set enrichment p-values for the
MSigDB C2 v4.0 gene sets, the AML versus ALL phenotype and the first three PCs of the Arm-
strong et al. leukemia gene expression data. Each of the columns in the multi-plot corresponds to
results for one PC and each row corresponds to one of the three different statistical tests supported
by PCGSE on the standardized mean difference gene set statistic (i.e., t-test, correlation-adjusted
t-test and permutation test). The association between PC 2 and the AML versus ALL phenotype
can be clearly seen in Figure 4 plots (b), (e) and (h). For all three PCGSE methods, the PC
enrichment p-values for the MSigDB C2 v4.0 gene sets are highly correlated with the enrichment
p-values computed for these gene sets relative to the AML versus ALL phenotype.
Similar to the PCGSE results outlined in previous sections on simulated data and yeast gene
expression data, the unadjusted two-sided t-test on the standardized mean difference gene set
statistic generates PC gene set enrichment p-values that are substantially lower than the enrichment
p-values output by either the correlation-adjusted t-test or the permutation test. Although the true
enrichment status of the MSigDB C2 v4.0 gene sets relative to the PCs of the Armstrong et al.
(2002) gene expression data is unknown, the phenotype enrichment results can be used as a proxy
for the true gene set association with PC 2 under the assumption that this PC captures the AML
versus ALL signal. If gene sets with a phenotype enrichment significance at or below 0.05 are
considered AML/ALL markers, the PCGSE method is able to correctly identify these gene sets via
enrichment relative to PC 2 with an area under the receiver operator characteristic curve (AUC) of
0.85 for the t-test results displayed in plot (b), an AUC of 0.89 for the correlation-adjusted t-test
results displayed in plot (e) and an AUC of 0.85 for the permutation test results displayed in plot
(h). Considering identification of AML/ALL-associated gene sets via PC enrichment using just
α =0.05, the PCGSE method has a positive predictive value of 0.26 for the t-test results displayed
in plot (b), 0.91 for the correlation-adjusted t-test results displayed in plot (e) and 0.46 for the
permutation test results displayed in plot (h).
PCGSE analysis of the MSigDB C2 v4.0 gene sets and Armstrong et al. (2002) leukemia gene
expression data illustrates the biological motivation for PC gene set enrichment and demonstrates
the superior performance of the computationally efficient correlation-adjusted t-test relative to
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Figure 4: Scatter plots showing the association between phenotype gene set enrichment p-values
and PC gene set enrichment p-values for the Armstrong et al. (2002) leukemia gene expression
data, AML/ALL phenotype, MSigDB C2 v4.0 gene sets and first three PCs. Both phenotype
and PC gene set enrichment p-values were computed as outlined in Section 2.9.3. The Spearman
correlation coefficient between phenotype and PC gene set enrichment p-values is displayed in each
plot. Plots (a)-(c) show the association between phenotype and PC gene set enrichment p-values
for PCs 1 through 3 with the PC enrichment p-values computed using a two-sided t-test on the
standardized mean difference gene set statistic. For plots (d)-(f), the PC gene set enrichment
p-values were computed using a correlation-adjusted two-sided t-test and, for plots (g)-(i), the PC
gene set enrichment p-values were computed using the permutation distribution of the gene set
statistic.
either an unadjusted t-test or permutation test.
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4 Conclusion
Although principal component analysis is widely used for the dimensional reduction of biomedical
data, with applications in visualization, clustering and regression, interpretation of PCA-based
models remains challenging. While rotation methods and sparse PCA techniques can generate
approximate PCs with few non-zero loadings that support interpretation in terms of individual
variables, these approaches will perform poorly on genomic data in which important biological
signals are defined by the collective action of groups of functionally related genes. Although gene
set testing methods have been widely applied to analyze the association between gene sets and
clinical phenotypes, such variable group testing methods have seen little application for testing
the association between gene sets and the spectra of genomic data.To address the challenge of
PC interpretation for genomic data and support the interpretation of genomic PCs in terms of
functional gene sets, we have developed the principal component gene set enrichment (PCGSE)
method. PCGSE performs a two-stage competitive gene set test using the correlation between
each gene and each PC as the gene-level test statistic with flexible choice of both the gene set
test statistic and the method used to compute the null distribution of the gene set statistic. To
facilitate use of the PCGSE method by other researchers, an implementation of the technique is
available as an R package from CRAN. On both simulated gene sets with simulated data and on
curated gene sets with real gene expression data, a computationally efficient version of the PCGSE
method based on a correlation-adjusted two-sided, two-sample t-test has been shown to accurately
compute the statistical association between gene sets and the PCs of genomic data.
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